Common use of Miscellaneous Clause in Contracts

Miscellaneous. Any provision of this Agreement that is determined by a court of competent jurisdiction to be invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction only, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. Any waiver of, or promise not to enforce, any right under this Agreement shall not be enforceable unless evidenced by a writing signed by the Discloser. This Agreement shall inure to the benefit of and be binding upon the parties hereto, and their successors and assigns. In the event this Agreement is translated for informational purposes, the Recipient hereby acknowledges and agree that the English version is the original language. In the event of a conflict of any purported inconsistency, the English version will prevail and shall be the binding version. This Agreement constitutes the final, entire, and exclusive agreement concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, written or oral, between Recipient and Discloser and/or Sponsor with respect thereto. Any modification, rescission or amendment of this Agreement shall not be effective unless made in writing executed by both parties. Each party agrees that it shall not make a public announcement of this Agreement, or any other agreement between the Parties, the discussions or the potential relationship, without the prior written consent of the other parties, except as may be required by any applicable law, rule or regulation of any governmental body. This Agreement shall not be construed as evidence of an intention to enter into business relations or transactions. The parties are independent contractors. This Agreement does not create any employment relationship, partnership or principal-agent. IN WITNESS WHEREOF, the Recipient hereto acknowledges that the representative named below has the authority to execute this Agreement on behalf of the Recipient to legally bind the Recipient to the terms of this Agreement. Dr. Xxxxxx Xxxxxxx Institution: Azienda Ospedaliera Universitaria Xxxxx - Istituto di Ricovero e Cura a Carattere Scientifico Signature : Signature: Print Name: Dr Xxxxx Xxxxxxx Xxxxxxxx Title: MD Title: CEO Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze (Signature) Print Name: Title: Date: 0xx Xxxxx, Xxxx Xxxx Xxxxxxxxx Xxxx, Nottingham, NG1 5FS, UK The purpose of this Privacy Notice is to provide information concerning the collection and use of your personal data in relation to the INZ701 Program (the “Study”) sponsored by Inozyme Pharma, Inc. (“Sponsor”) and managed by its contract research organization Worldwide Clinical Trials (“Worldwide”). In connection with the Study, personal data may be collected from members of the Study team by or on behalf of Sponsor or Worldwide, in particular: • Name and contact details; • Where applicable, your professional identification number; • Office / practice location, type, amenities, contact and communication preferences • Curriculum vitae, including any licenses, certifications and professional affiliations; • Information about debarment and any professional discipline measures from government sources or professional organizations • Declaration of financial interests, if applicable; • Affiliation with a Site Management Organization (“SMO”) • Financial information collected for payment • Historical and current information regarding participation and performance in clinical studies; • Training records; and • Authentication information for entering data into the eCRF (electronic case report form). The Sponsor of the study, who is the controller of the personal data described above, either itself or through a service provider (including Worldwide), may collect, process, store and use the personal data for the following purposes:

Miscellaneous. Any provision The delay or failure of this Agreement that is determined by a court either Party to enforce at any time or for any period of competent jurisdiction to be invalid, illegal or unenforceable in time any jurisdiction shall, as to that jurisdiction only, be ineffective to of the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. Any waiver of, or promise not to enforce, any right under this Agreement shall not be enforceable unless evidenced by a writing signed by the Discloser. This Agreement shall inure to the benefit of and be binding upon the parties hereto, and their successors and assigns. In the event this Agreement is translated for informational purposes, the Recipient hereby acknowledges and agree that the English version is the original language. In the event of a conflict of any purported inconsistency, the English version will prevail and shall be the binding version. This Agreement constitutes the final, entire, and exclusive agreement concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, written or oral, between Recipient and Discloser and/or Sponsor with respect thereto. Any modification, rescission or amendment of this Agreement shall not be effective unless made in writing executed by both partiesconstrued as a waiver of such provisions or of the right of the Party to thereafter seek their enforcement. The Parties claim that all rights that allow the signing and performance of this Agreement and that allows the other Party to perform the obligations set forth herein, belong to them. Each party agrees Party claims that it shall not make a public announcement the signing and performance of this Agreement, agreement and the rights set forth herein do not compromise any third party rights. If one or any other agreement between more of the Partiesprovisions of this Agreement should be or become invalid or impracticable, the discussions or the potential relationship, without the prior written consent validity of the other parties, except as may be required by any applicable law, rule or regulation of any governmental body. This Agreement remaining provisions shall not be construed as evidence of an intention to enter into business relations or transactionsaffected. The parties are independent contractors. This Agreement does not create Parties shall in good faith make any employment relationship, partnership efforts to replace the invalid or principal-agent. IN WITNESS WHEREOF, the Recipient hereto acknowledges that the representative named below has the authority to execute this Agreement on behalf of the Recipient to legally bind the Recipient impracticable provision by an effective provision which must closely approximate to the terms purpose of this Agreement. Dr. IZSVe and Anixa will act all times as independent contractors. Nothing contained herein shall be construed or applied so as to create the relationship of principal and agent or of employer and employee between IZSVe and Anixa or any partnership or joint-venture. Neither Party shall make any commitment or incur any charge or expense in the name of the other Party. This Agreement may be amended, modified, superseded or canceled, only by a written instrument executed by each Party’s duly authorized representatives. All notices and communications related to this agreement shall be made by registered or certified letter, return receipt requested, tele copier, email or electronic transmission confirmed in writing by register letter and shall be addressed as follows (or to other address as may hereafter be designed by written notice): If to IZSVe: Att. Xxxxxxxxx Xxxxxxxx Istituto Zooprofilattico Sperimentale delle Venezie Viale dell’Università 10 00000 - Xxxxxxx (XX) XXXXX e-mail xxxxxxxxx@xxxxxxxxxx.xx Support secretarial office: Xxxxxxxxx Xxxxxx – xxxxxxx@xxxxxxxxxx.xx If to Anixa: Att. Xxxx Xxxxx Anixa Biosciences, Inc. 0000 Xxxxxxx Institution: Azienda Ospedaliera Universitaria Xxxxxxxxxx, Xxxxx - Istituto di Ricovero e Cura a Carattere Scientifico Signature : Signature: Print Name: Dr Xxxxx Xxxxxxx Xxxxxxxx Title: MD Title: CEO Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze (Signature) Print Name: Title: Date: 0xx Xxxxx, Xxxx Xxxx Xxxxxxxxx 000 Xxx Xxxx, Nottingham, NG1 5FS, UK The purpose of this Privacy Notice is to provide information concerning the collection and use of your personal data in relation to the INZ701 Program (the “Study”) sponsored by Inozyme Pharma, Inc. (“Sponsor”) and managed by its contract research organization Worldwide Clinical Trials (“Worldwide”). In connection with the Study, personal data may be collected from members of the Study team by or on behalf of Sponsor or Worldwide, in particular: • Name and contact details; • Where applicable, your professional identification number; • Office / practice location, type, amenities, contact and communication preferences • Curriculum vitae, including any licenses, certifications and professional affiliations; • Information about debarment and any professional discipline measures from government sources or professional organizations • Declaration of financial interests, if applicable; • Affiliation with a Site Management Organization (“SMO”) • Financial information collected for payment • Historical and current information regarding participation and performance in clinical studies; • Training records; and • Authentication information for entering data into the eCRF (electronic case report form). The Sponsor of the study, who is the controller of the personal data described above, either itself or through a service provider (including Worldwide), may collect, process, store and use the personal data for the following purposes:CA 95125 USA email xx@xxxxx.xxx

Miscellaneous. Any provision The delay or failure of either Party to enforce at any time or for any period of time any of the provisions of this agreement shall not be construed as a waiver of such provisions or of the right of the Party to thereafter seek their enforcement. The Parties claim that all rights that allow the signing and performance of this agreement and that allow the other Party to perform the obligations set forth herein, belong to them. Each Party claims that the signing and performance of this agreement and the rights set forth herein do not compromise any third party rights. If one or more of the provisions of this Agreement that is determined by a court should be or become invalid or impracticable, the validity of competent jurisdiction to be invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction only, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. Any waiver of, or promise not to enforce, any right under this Agreement shall not be enforceable unless evidenced effected. The Parties shall in good faith make any efforts to replace the invalid or impracticable provision by a writing signed by an effective provision which must closely approximate to the Discloserpurpose of this Agreement. IZSVe and the Company will act all times as independent contractors. Nothing contained herein shall be construed or applied so as to create the relationship of principal and agent or of employer and employee between IZSVe and the Company or any partnership or joint-venture. Neither Party shall make any commitment or incur any charge or expense in the name of the other Party. This Agreement shall inure to and the benefit of rights and be binding upon the parties hereto, and their successors and assigns. In the event this Agreement is translated for informational purposes, the Recipient hereby acknowledges and agree that the English version is the original language. In the event of a conflict of any purported inconsistency, the English version will prevail and shall be the binding version. This Agreement constitutes the final, entire, and exclusive agreement concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, written or oral, between Recipient and Discloser and/or Sponsor with respect thereto. Any modification, rescission or amendment of this Agreement shall duties set forth herein may not be effective unless made in writing executed assigned, transferred, delegated or sub-contracted by both parties. Each party agrees that it shall not make a public announcement of this Agreement, or any other agreement between the Parties, the discussions or the potential relationship, either Party without the prior written consent of the other partiesParty. For anything not expressly regulated by this contract, except as may be required by any applicable lawthe parties will make exclusive reference to the legislation in force in the Italian legal system, rule in particular the laws of the Civil Code and the general conditions of contract available on the Institute's website (xxx.xxxxxxxxxx.xx) and subsequent amendments and / or regulation of any governmental bodyadditions. This Agreement may be amended, modified, superseded or canceled, only by a written instrument executed by each Party’s duly authorized representatives. All notices and communications related to this agreement shall not be construed made by registered or certified letter, return receipt requested, telecopier or electronic transmission confirmed in writing by register letter and shall be addressed as evidence of an intention follows (or to enter into business relations or transactionsother address as may hereafter be designed by written notice): If to IZSVe: Att. The parties are independent contractors. This Agreement does not create any employment relationship, partnership or principalDr. Xxxxxxxxx Xxxxxxxx/Xxxxxxx Xxxxxxxxx Istituto Zooprofilattico Sperimentale delle Venezie Viale dell’Università 10 00000 - Xxxxxxx (XX) XXXXX email: xxxxxxxxx@xxxxxxxxxx.xx Xxxxxxxxx Xxxxxx – Support Office e-agent. IN WITNESS WHEREOF, the Recipient hereto acknowledges that the representative named below has the authority to execute this Agreement on behalf of the Recipient to legally bind the Recipient mail: xxxxxxx@xxxxxxxxxx.xx If to the terms of this AgreementCompany: Att. Dr. Xxxxxx Xxxxxxx InstitutionXxxx Biovac LTD Or-Akiva, Israel 3060000 Email: Azienda Ospedaliera Universitaria Xxxxx - Istituto di Ricovero e Cura a Carattere Scientifico Signature : Signature: Print Name: Dr Xxxxx Xxxxxxx Xxxxxxxx Title: MD Title: CEO Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze (Signature) Print Name: Title: Date: 0xx Xxxxx, Xxxx Xxxx Xxxxxxxxx Xxxx, Nottingham, NG1 5FS, UK The purpose of this Privacy Notice is to provide information concerning the collection and use of your personal data in relation to the INZ701 Program (the “Study”) sponsored by Inozyme Pharma, Inc. (“Sponsor”) and managed by its contract research organization Worldwide Clinical Trials (“Worldwide”). In connection with the Study, personal data may be collected from members of the Study team by or on behalf of Sponsor or Worldwide, in particular: • Name and contact details; • Where applicable, your professional identification number; • Office / practice location, type, amenities, contact and communication preferences • Curriculum vitae, including any licenses, certifications and professional affiliations; • Information about debarment and any professional discipline measures from government sources or professional organizations • Declaration of financial interests, if applicable; • Affiliation with a Site Management Organization (“SMO”) • Financial information collected for payment • Historical and current information regarding participation and performance in clinical studies; • Training records; and • Authentication information for entering data into the eCRF (electronic case report form). The Sponsor of the study, who is the controller of the personal data described above, either itself or through a service provider (including Worldwide), may collect, process, store and use the personal data for the following purposes:xxxxxxx@xxxxxx.xx.xx

Miscellaneous. Any provision The delay or failure of this Agreement that is determined by a court either Party to enforce at any time or for any period of competent jurisdiction to be invalid, illegal or unenforceable in time any jurisdiction shall, as to that jurisdiction only, be ineffective to of the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. Any waiver of, or promise not to enforce, any right under this Agreement shall not be enforceable unless evidenced by a writing signed by the Discloser. This Agreement shall inure to the benefit of and be binding upon the parties hereto, and their successors and assigns. In the event this Agreement is translated for informational purposes, the Recipient hereby acknowledges and agree that the English version is the original language. In the event of a conflict of any purported inconsistency, the English version will prevail and shall be the binding version. This Agreement constitutes the final, entire, and exclusive agreement concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, written or oral, between Recipient and Discloser and/or Sponsor with respect thereto. Any modification, rescission or amendment of this Agreement shall not be construed as a waiver of such provisions or of the right of the Party to thereafter seek their enforcement. The Parties claim that all rights that allow the signing and performance of this Agreement and that allow the other Party to perform the obligations set forth herein, belong to them. Each Party claims that the signing and performance of this Agreement and the rights set forth herein do not compromise any third party rights. If one or more of the provisions of this Agreement should be or become invalid or impracticable, the validity of the remaining provisions shall not be affected. The Parties shall in good faith make any efforts to replace the invalid or impracticable provision by an effective unless made provision which must closely approximate to the purpose of this Agreement and such modification shall be agreed and executed in writing executed by both partiesthe Parties. Each party agrees that it IZSVe and the Company will act all times as independent contractors. Nothing contained herein shall not make a public announcement be construed or applied so as to create the relationship of this Agreement, principal and agent or of employer and employee between IZSVe and the Company or any partnership or joint-venture. Neither Party shall make any commitment or incur any charge or expense in the name of the other agreement between Party. This Agreement and the Partiesrights and duties set forth herein may not be assigned, the discussions transferred, delegated or the potential relationship, sub-contracted by either Party without the prior written consent of the other partiesParty. For anything not expressly regulated by this Agreement, except as may be required by any applicable lawthe Parties will make exclusive reference to the legislation in force in the Italian legal system, rule in particular the laws of the Civil Code and the general conditions of contract available on the Institute's website (xxx.xxxxxxxxxx.xx) and subsequent amendments and / or regulation of any governmental bodyadditions. This Agreement shall not may be construed as evidence of an intention amended, modified, superseded or canceled, only by a written instrument executed by both Parties’ duly authorized representatives. All notices and communications related to enter into business relations or transactions. The parties are independent contractors. This Agreement does not create any employment relationship, partnership or principal-agent. IN WITNESS WHEREOF, the Recipient hereto acknowledges that the representative named below has the authority to execute this Agreement on behalf of the Recipient shall be made by registered or certified letter, return receipt requested, telecopier or electronic transmission confirmed in writing by register letter and shall be addressed as follows (or to legally bind the Recipient other address as may hereafter be designed by written notice): If to IZSVe: Att. Xxxxxxxxx Xxxxxxxx Istituto Zooprofilattico Sperimentale delle Venezie Viale dell’Università 10 00000 - Xxxxxxx (XX) XXXXX e-mail: xxxxxxxxx@xxxxxxxxxx.xx If to the terms of this AgreementCompany: Att. Dr. Xxxxxx Xxxxxxx Institution: Azienda Ospedaliera Universitaria Xxxxxxxxx Xxxxx - Istituto di Ricovero e Cura a Carattere Scientifico Signature : Signature: Print Name: Dr Laboratorio AVI-MEX, S.A. de C.V. Bartolache 0000, Xxxxx Xxxxxxx Xxxxxxxx Title: MD Title: CEO Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze (Signature) Print Name: Title: Date: 0xx Xxxxx, Xxx. Xxx Xxxxx, Xxx Xxxx Xxxx Xxxxxxxxx 00000, Xxxxxx Xxxx, Nottingham, NG1 5FS, UK The purpose of this Privacy Notice is to provide information concerning the collection and use of your personal data in relation to the INZ701 Program (the “Study”) sponsored by Inozyme Pharma, Inc. (“Sponsor”) and managed by its contract research organization Worldwide Clinical Trials (“Worldwide”). In connection with the Study, personal data may be collected from members of the Study team by or on behalf of Sponsor or Worldwide, in particularXxxxxx e-mail: • Name and contact details; • Where applicable, your professional identification number; • Office / practice location, type, amenities, contact and communication preferences • Curriculum vitae, including any licenses, certifications and professional affiliations; • Information about debarment and any professional discipline measures from government sources or professional organizations • Declaration of financial interests, if applicable; • Affiliation with a Site Management Organization (“SMO”) • Financial information collected for payment • Historical and current information regarding participation and performance in clinical studies; • Training records; and • Authentication information for entering data into the eCRF (electronic case report form). The Sponsor of the study, who is the controller of the personal data described above, either itself or through a service provider (including Worldwide), may collect, process, store and use the personal data for the following purposes:xxxxxxxxx.xxxxx@xxxxxx.xxx.xx

Miscellaneous. Any provision The delay or failure of this Agreement that is determined by a court either Party to enforce at any time or for any period of competent jurisdiction to be invalid, illegal or unenforceable in time any jurisdiction shall, as to that jurisdiction only, be ineffective to of the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. Any waiver of, or promise not to enforce, any right under this Agreement shall not be enforceable unless evidenced by a writing signed by the Discloser. This Agreement shall inure to the benefit of and be binding upon the parties hereto, and their successors and assigns. In the event this Agreement is translated for informational purposes, the Recipient hereby acknowledges and agree that the English version is the original language. In the event of a conflict of any purported inconsistency, the English version will prevail and shall be the binding version. This Agreement constitutes the final, entire, and exclusive agreement concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, written or oral, between Recipient and Discloser and/or Sponsor with respect thereto. Any modification, rescission or amendment of this Agreement shall not be effective unless made in writing executed by both partiesconstrued as a waiver of such provisions or of the right of the Party to thereafter seek their enforcement. The Parties claim that all rights that allow the signing and performance of this Agreement and that allows the other Party to perform the obligations set forth herein, belong to them. Each party agrees Party claims that it shall not make a public announcement the signing and performance of this Agreement, agreement and the rights set forth herein do not compromise any third party rights. If one or any other agreement between more of the Partiesprovisions of this Agreement should be or become invalid or impracticable, the discussions or the potential relationship, without the prior written consent validity of the other parties, except as may be required by any applicable law, rule or regulation of any governmental body. This Agreement remaining provisions shall not be construed as evidence of an intention to enter into business relations or transactionseffected. The parties are independent contractors. This Agreement does not create Parties shall in good faith make any employment relationship, partnership efforts to replace the invalid or principal-agent. IN WITNESS WHEREOF, the Recipient hereto acknowledges that the representative named below has the authority to execute this Agreement on behalf of the Recipient to legally bind the Recipient impracticable provision by an effective provision which must closely approximate to the terms purpose of this Agreement. Dr. IZSVe and the Company will act all times as independent contractors. Nothing contained herein shall be construed or applied so as to create the relationship of principal and agent or of employer and employee between IZSVe and the Company or any partnership or joint-venture. Neither Party shall make any commitment or incur any charge or expense in the name of the other Party. This Agreement may be amended, modified, superseded or canceled, only by a written instrument executed by each Party’s duly authorized representatives. All notices and communications related to this agreement shall be made by registered or certified letter, return receipt requested, telecopier, email or electronic transmission confirmed in writing by register letter and shall be addressed as follows (or to other address as may hereafter be designed by written notice): If to IZSVe: Att. Xxxxxxxxx Xxxxxxxx Istituto Zooprofilattico Sperimentale delle Venezie Viale dell’Università 10 00000 - Xxxxxxx (XX) XXXXX e-mail xxxxxxxxx@xxxxxxxxxx.xx….. If to the Company: Att. Xxxxxxxx Xxxxxxxx Xxxxx, Xxxxxx Xxxxx Xxxxxxxx Durante y Xxxxxxx Xxxxxx Xxxxxxxx Xxxxxxxxx Laboratorios Sanfer, S.A. de C.V.Blvd. Xxxxxx Xxxxx Xxxxxx No. 314, Colonia Tlacopac Alcaldía Xxxxxx Xxxxxxx Institution: Azienda Ospedaliera Universitaria Xxxxx - Istituto di Ricovero e Cura a Carattere Scientifico Signature : Signature: Print Name: Dr Xxxxx Xxxxxxx Xxxxxxxx Title: MD Title: CEO Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze (Signature) Print Name: Title: Date: 0xx Xxxxx, Xxxx Xxxx Xxxxxxxxx 00000 Xxxxxx Xxxx, Nottingham, NG1 5FS, UK The purpose of this Privacy Notice is to provide information concerning the collection Xxxxxx email xxxxxxxxx@xxxxxx.xxx.xx; xxxxxx.xxxxxxxx@xxxxxx.xxx.xx and use of your personal data in relation to the INZ701 Program (the “Study”) sponsored by Inozyme Pharma, Inc. (“Sponsor”) and managed by its contract research organization Worldwide Clinical Trials (“Worldwide”). In connection with the Study, personal data may be collected from members of the Study team by or on behalf of Sponsor or Worldwide, in particular: • Name and contact details; • Where applicable, your professional identification number; • Office / practice location, type, amenities, contact and communication preferences • Curriculum vitae, including any licenses, certifications and professional affiliations; • Information about debarment and any professional discipline measures from government sources or professional organizations • Declaration of financial interests, if applicable; • Affiliation with a Site Management Organization (“SMO”) • Financial information collected for payment • Historical and current information regarding participation and performance in clinical studies; • Training records; and • Authentication information for entering data into the eCRF (electronic case report form). The Sponsor of the study, who is the controller of the personal data described above, either itself or through a service provider (including Worldwide), may collect, process, store and use the personal data for the following purposes:xxxxxxx.xxxxxxxx@xxxxxx.xxx.xx

Miscellaneous. Any provision The delay or failure of either Party to enforce at any time or for any period of time any of the provisions of this agreement shall not be construed as a waiver of such provisions or of the right of the Party to thereafter seek their enforcement. The Parties claim that all rights that allow the signing and performance of this agreement and that allow the other Party to perform the obligations set forth herein, belong to them. Each Party claims that the signing and performance of this agreement and the rights set forth herein do not compromise any third party rights. If one or more of the provisions of this Agreement that is determined by a court should be or become invalid or impracticable, the validity of competent jurisdiction to be invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction only, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. Any waiver of, or promise not to enforce, any right under this Agreement shall not be enforceable unless evidenced effected. The Parties shall in good faith make any efforts to replace the invalid or impracticable provision by a writing signed by an effective provision which must closely approximate to the Discloserpurpose of this Agreement. IZSVe and IRVT will act all times as independent contractors. Nothing contained herein shall be construed or applied so as to create the relationship of principal and agent or of employer and employee between IZSVe and IRVT or any partnership or joint-venture. Neither Party shall make any commitment or incur any charge or expense in the name of the other Party. This Agreement shall inure to and the benefit of rights and be binding upon the parties hereto, and their successors and assigns. In the event this Agreement is translated for informational purposes, the Recipient hereby acknowledges and agree that the English version is the original language. In the event of a conflict of any purported inconsistency, the English version will prevail and shall be the binding version. This Agreement constitutes the final, entire, and exclusive agreement concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, written or oral, between Recipient and Discloser and/or Sponsor with respect thereto. Any modification, rescission or amendment of this Agreement shall duties set forth herein may not be effective unless made in writing executed assigned, transferred, delegated or sub-contracted by both parties. Each party agrees that it shall not make a public announcement of this Agreement, or any other agreement between the Parties, the discussions or the potential relationship, either Party without the prior written consent of the other partiesParty. For anything not expressly regulated by this contract, except as may be required by any applicable lawthe parties will make exclusive reference to the legislation in force in the Italian legal system, rule in particular the laws of the Civil Code and the general conditions of contract available on the Institute's website (xxx.xxxxxxxxxx.xx) and subsequent amendments and / or regulation of any governmental bodyadditions. This Agreement may be amended, modified, superseded or canceled, only by a written instrument executed by each Party’s duly authorized representatives. All notices and communications related to this agreement shall not be construed made by registered or certified letter, return receipt requested, telecopier or electronic transmission confirmed in writing by register letter and shall be addressed as evidence of an intention follows (or to enter into business relations or transactions. The parties are independent contractors. This Agreement does not create any employment relationship, partnership or principal-agent. IN WITNESS WHEREOF, the Recipient hereto acknowledges that the representative named below has the authority other address as may hereafter be designed by written notice): If to execute this Agreement on behalf IZSVe: Xxxxx Xx Xxxxxxxxxx Responsible of the Recipient FAO-UN/National reference centers for rabies Xxxxxxxxx Xxxxxx Administration/Secretarial support Istituto Zooprofilattico Sperimentale delle Venezie Viale dell’Università 10 00000 - Xxxxxxx (XX) XXXXX Fax +00-000-0000000. e-mail: xxxxxxxxxxxxx@xxxxxxxxxx.xx email: xxxxxxx@xxxxxxxxxx.xx If to legally bind the Recipient to the terms of this Agreement. Dr. IRVT: Prof. Xxxxxxxxxxx Xxx Xxxxxxx General Director Tunisian Veterinary Research Institute 00 Xxx Xxxxxx Xxxxxxx Institution: Azienda Ospedaliera Universitaria Xxxxx - Istituto di Ricovero e Cura a Carattere Scientifico Signature : Signature: Print Name: Dr Xxxxx Xxxxxxx Xxxxxxxx Title: MD Title: CEO Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze (Signature) Print Name: Title: Date: 0xx xx Xxxxx, Xxxx Xxxx Xxxxxxxxx Xxxx0000 Xxxxx, Nottingham, NG1 5FS, UK The purpose of this Privacy Notice is to provide information concerning the collection and use of your personal data in relation to the INZ701 Program (the “Study”) sponsored by Inozyme Pharma, Inc. (“Sponsor”) and managed by its contract research organization Worldwide Clinical Trials (“Worldwide”). In connection with the Study, personal data may be collected from members of the Study team by or on behalf of Sponsor or Worldwide, in particularXxxxxxx Fax +00000000000 e-mail: • Name and contact details; • Where applicable, your professional identification number; • Office / practice location, type, amenities, contact and communication preferences • Curriculum vitae, including any licenses, certifications and professional affiliations; • Information about debarment and any professional discipline measures from government sources or professional organizations • Declaration of financial interests, if applicable; • Affiliation with a Site Management Organization (“SMO”) • Financial information collected for payment • Historical and current information regarding participation and performance in clinical studies; • Training records; and • Authentication information for entering data into the eCRF (electronic case report form). The Sponsor of the study, who is the controller of the personal data described above, either itself or through a service provider (including Worldwide), may collect, process, store and use the personal data for the following purposes:xxxxxxxxxxx@xxxxx.xx

Miscellaneous. Any provision of this Agreement that is determined by a court of competent jurisdiction to be invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction only, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. Any waiver of, or promise not to enforce, any right under this Agreement shall not be enforceable unless evidenced by a writing signed by the Discloser. This Agreement shall inure to the benefit of and be binding upon the parties hereto, and their successors and assigns. In the event this Agreement is translated for informational purposes, the Recipient hereby acknowledges and agree that the English version is the original language. In the event of a conflict of any purported inconsistency, the English version will prevail and shall be the binding version. This Agreement constitutes the final, entire, and exclusive agreement concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, written or oral, between Recipient and Discloser and/or Sponsor with respect thereto. Any modification, rescission or amendment of this Agreement shall not be effective unless made in writing executed by both parties. Each party agrees that it shall not make a public announcement of this Agreement, or any other agreement between the Parties, the discussions or the potential relationship, without the prior written consent of the other parties, except as may be required by any applicable law, rule or regulation of any governmental body. This Agreement shall not be construed as evidence of an intention to enter into business relations or transactions. The parties are independent contractors. This Agreement does not create any employment relationship, partnership or principal-agent. IN WITNESS WHEREOF, the Recipient hereto acknowledges that the representative named below has the authority to execute this Agreement on behalf of the Recipient to legally bind the Recipient to the terms of this Agreement. Dr. Xxxxxx Xxxxxxx Xxxxxxxx Institution: Azienda Ospedaliera Universitaria Xxxxx - Istituto di Ricovero e Cura a Carattere Scientifico Signature : Signature: Print Name: Dr Xxxxx Xxxxxxx Xxxxxxxx Title: MD Title: CEO Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze (Signature) Print Name: Title: Date: 0xx Xxxxx, Xxxx Xxxx Xxxxxxxxx Xxxx, Nottingham, NG1 5FS, UK The purpose of this Privacy Notice is to provide information concerning the collection and use of your personal data in relation to the INZ701 Program (the “Study”) sponsored by Inozyme Pharma, Inc. (“Sponsor”) and managed by its contract research organization Worldwide Clinical Trials (“Worldwide”). In connection with the Study, personal data may be collected from members of the Study team by or on behalf of Sponsor or Worldwide, in particular: • Name and contact details; • Where applicable, your professional identification number; • Office / practice location, type, amenities, contact and communication preferences • Curriculum vitae, including any licenses, certifications and professional affiliations; • Information about debarment and any professional discipline measures from government sources or professional organizations • Declaration of financial interests, if applicable; • Affiliation with a Site Management Organization (“SMO”) • Financial information collected for payment • Historical and current information regarding participation and performance in clinical studies; • Training records; and • Authentication information for entering data into the eCRF (electronic case report form). The Sponsor of the study, who is the controller of the personal data described above, either itself or through a service provider (including Worldwide), may collect, process, store and use the personal data for the following purposes:

Miscellaneous. Any provision The delay or failure of either Party to enforce at any time or for any period of time any of the provisions of this agreement shall not be construed as a waiver of such provisions or of the right of the Party to thereafter seek their enforcement. The Parties claim that all rights that allow the signing and performance of this agreement and that allow the other Party to perform the obligations set forth herein, belong to them. Each Party claims that the signing and performance of this agreement and the rights set forth herein do not compromise any third-party rights. If one or more of the provisions of this Agreement that is determined by a court should be or become invalid or impracticable, the validity of competent jurisdiction to be invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction only, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. Any waiver of, or promise not to enforce, any right under this Agreement shall not be enforceable unless evidenced affected. The Parties shall in good faith make any efforts to replace the invalid or impracticable provision by a writing signed by an effective provision which must closely approximate to the Discloserpurpose of this Agreement. IZSVe and the Company will act all times as independent suppliers. Nothing contained herein shall be construed or applied so as to create the relationship of principal and agent or of employer and employee between IZSVe and the Company or any partnership or joint venture. Neither Party shall make any commitment or incur any charge or expense in the name of the other Party. This Agreement shall inure to and the benefit of rights and be binding upon the parties hereto, and their successors and assigns. In the event this Agreement is translated for informational purposes, the Recipient hereby acknowledges and agree that the English version is the original language. In the event of a conflict of any purported inconsistency, the English version will prevail and shall be the binding version. This Agreement constitutes the final, entire, and exclusive agreement concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, written or oral, between Recipient and Discloser and/or Sponsor with respect thereto. Any modification, rescission or amendment of this Agreement shall duties set forth herein may not be effective unless made in writing executed assigned, transferred, delegated or sub-contracted by both parties. Each party agrees that it shall not make a public announcement of this Agreement, or any other agreement between the Parties, the discussions or the potential relationship, either Party without the prior written consent of the other partiesParty. For anything not expressly regulated by this agreement, except as may be required by any applicable lawthe parties will make exclusive reference to the legislation in force in the Italian legal system, rule in particular the laws of the Civil Code and the general conditions of contract available on the Institute's website (xxx.xxxxxxxxxx.xx) and subsequent amendments and / or regulation of any governmental bodyadditions. This Agreement may be amended, modified, superseded or canceled, only by a written instrument executed by each Party’s duly authorized representatives. All notices and communications related to this agreement shall not be construed made by registered or certified letter, return receipt requested, telecopier or electronic transmission confirmed in writing by register letter and shall be addressed as evidence of an intention follows (or to enter into business relations or transactionsother address as may hereafter be designed by written notice): If to IZSVe: Att. The parties are independent contractors. This Agreement does not create any employment relationship, partnership or principalDr. Xxxxxxxxx Xxxxxxxx Istituto Zooprofilattico Sperimentale delle Venezie Viale dell’Università 10 00000 - Xxxxxxx (XX) XXXXX email: xxxxxxxxx@xxxxxxxxxx.xx Xxxxxxxxx Xxxxxx – Support Office e-agent. IN WITNESS WHEREOF, the Recipient hereto acknowledges that the representative named below has the authority to execute this Agreement on behalf of the Recipient to legally bind the Recipient mail: xxxxxxx@xxxxxxxxxx.xx If to the terms of this AgreementCompany: Att. Dr. Xxxxxx Xxxxxxx Institution: Azienda Ospedaliera Universitaria Xxxxx - Istituto di Ricovero e Cura a Carattere Scientifico Signature : Signature: Print Name: Dr Xxxxx Xxxxxxx Xxxxxxxx Title: MD Title: CEO Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze (Signature) Print Name: Title: Date: 0xx Professor Xxx X Xxxxx, Xxxx Xxxx Xxxxxxxxx OBE, MIBiol PhD Head of Virology Department Address: XXXX Xxxxxxxxx, Xxxxxxx Xxxx, NottinghamNew Haw, NG1 5FS, UK The purpose of this Privacy Notice is to provide information concerning the collection and use of your personal data in relation to the INZ701 Program (the “Study”) sponsored by Inozyme Pharma, Inc. (“Sponsor”) and managed by its contract research organization Worldwide Clinical Trials (“Worldwide”)Addlestone. In connection with the Study, personal data may be collected from members of the Study team by or on behalf of Sponsor or Worldwide, in particularSurrey. KT15 3NB Email: • Name and contact details; • Where applicable, your professional identification number; • Office / practice location, type, amenities, contact and communication preferences • Curriculum vitae, including any licenses, certifications and professional affiliations; • Information about debarment and any professional discipline measures from government sources or professional organizations • Declaration of financial interests, if applicable; • Affiliation with a Site Management Organization (“SMO”) • Financial information collected for payment • Historical and current information regarding participation and performance in clinical studies; • Training records; and • Authentication information for entering data into the eCRF (electronic case report form). The Sponsor of the study, who is the controller of the personal data described above, either itself or through a service provider (including Worldwide), may collect, process, store and use the personal data for the following purposes:Xxx.Xxxxx@xxxx.xxx.xx

Miscellaneous. Any provision The delay or failure of either Party to enforce at any time or for any period of time any of the provisions of this agreement shall not be construed as a waiver of such provisions or of the right of the Party to thereafter seek their enforcement. The Parties claim that all rights that allow the signing and performance of this agreement and that allow the other Party to perform the obligations set forth herein, belong to them. Each Party claims that the signing and performance of this agreement and the rights set forth herein do not compromise any third party rights. If one or more of the provisions of this Agreement that is determined by a court should be or become invalid or impracticable, the validity of competent jurisdiction to be invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction only, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal or unenforceable in any other jurisdiction. Any waiver of, or promise not to enforce, any right under this Agreement shall not be enforceable unless evidenced effected. The Parties shall in good faith make any efforts to replace the invalid or impracticable provision by a writing signed by an effective provision which must closely approximate to the Discloserpurpose of this Agreement. IZSVe and the Company will act all times as independent contractors. Nothing contained herein shall be construed or applied so as to create the relationship of principal and agent or of employer and employee between IZSVe and the Company or any partnership or joint-venture. Neither Party shall make any commitment or incur any charge or expense in the name of the other Party. This Agreement shall inure to and the benefit of rights and be binding upon the parties hereto, and their successors and assigns. In the event this Agreement is translated for informational purposes, the Recipient hereby acknowledges and agree that the English version is the original language. In the event of a conflict of any purported inconsistency, the English version will prevail and shall be the binding version. This Agreement constitutes the final, entire, and exclusive agreement concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, written or oral, between Recipient and Discloser and/or Sponsor with respect thereto. Any modification, rescission or amendment of this Agreement shall duties set forth herein may not be effective unless made in writing executed assigned, transferred, delegated or sub-contracted by both parties. Each party agrees that it shall not make a public announcement of this Agreement, or any other agreement between the Parties, the discussions or the potential relationship, either Party without the prior written consent of the other partiesParty. For anything not expressly regulated by this contract, except as may be required by any applicable lawthe parties will make exclusive reference to the legislation in force in the Italian legal system, rule in particular the laws of the Civil Code and the general conditions of contract available on the Institute's website (xxx.xxxxxxxxxx.xx) and subsequent amendments and / or regulation of any governmental bodyadditions. This Agreement may be amended, modified, superseded or canceled, only by a written instrument executed by each Party’s duly authorized representatives. All notices and communications related to this agreement shall not be construed made by registered or certified letter, return receipt requested, telecopier or electronic transmission confirmed in writing by register letter and shall be addressed as evidence of an intention follows (or to enter into business relations or transactionsother address as may hereafter be designed by written notice): If to IZSVe: Att. The parties are independent contractors. This Agreement does not create any employment relationship, partnership or principalXxxx Xxxxxx Istituto Zooprofilattico Sperimentale delle Venezie Viale dell’Università 10 00000 - Xxxxxxx (XX) XXXXX Fax 0039/000000000 e-agent. IN WITNESS WHEREOF, the Recipient hereto acknowledges that the representative named below has the authority to execute this Agreement on behalf of the Recipient to legally bind the Recipient mail xxxxxxx@xxxxxxxxxx.xx If to the terms of this AgreementCompany: Att. Dr. Xxxxxx Xxxxxxx Institution: Azienda Ospedaliera Universitaria AquaBioTech Ltd. ‘Central Complex’ Xxxxxx Xxx., Xxxxx - Istituto di Ricovero e Cura a Carattere Scientifico Signature : Signature: Print Name: Dr Xxxxx Xxxxxxx Xxxxxxxx Title: MD Title: CEO Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze Date: Address for notice: Xxxxx X. Xxxxxxxxxx 24 50139 Firenze (Signature) Print Name: Title: Date: 0xx XXX0000 Xxxxx, Xxxx Xxxx Xxxxxxxxx Xxxx, Nottingham, NG1 5FS, UK The purpose of this Privacy Notice is to provide information concerning the collection and use of your personal data in relation to the INZ701 Program (the “Study”) sponsored by Inozyme Pharma, Inc. (“Sponsor”) and managed by its contract research organization Worldwide Clinical Trials (“Worldwide”). In connection with the Study, personal data may be collected from members of the Study team by or on behalf of Sponsor or Worldwide, in particular: • Name and contact details; • Where applicable, your professional identification number; • Office / practice location, type, amenities, contact and communication preferences • Curriculum vitae, including any licenses, certifications and professional affiliations; • Information about debarment and any professional discipline measures from government sources or professional organizations • Declaration of financial interests, if applicable; • Affiliation with a Site Management Organization (“SMO”) • Financial information collected for payment • Historical and current information regarding participation and performance in clinical studies; • Training records; and • Authentication information for entering data into the eCRF (electronic case report form). The Sponsor of the study, who is the controller of the personal data described above, either itself or through a service provider (including Worldwide), may collect, process, store and use the personal data for the following purposes:.